Literature DB >> 10973926

Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells.

Y Canitrot1, J S Hoffmann, P Calsou, H Hayakawa, B Salles, C Cazaux.   

Abstract

The nucleotide excision repair pathway contributes to genetic stability by removing a wide range of DNA damage through an error-free reaction. When the lesion is located, the altered strand is incised on both sides of the lesion and a damaged oligonucleotide excised. A repair patch is then synthesized and the repaired strand is ligated. It is assumed that only DNA polymerases delta and/or epsilon participate to the repair DNA synthesis step. Using UV and cisplatin-modified DNA templates, we measured in vitro that extracts from cells overexpressing the error-prone DNA polymerase beta exhibited a five- to sixfold increase of the ultimate DNA synthesis activity compared with control extracts and demonstrated the specific involvement of Pol beta in this step. By using a 28 nt gapped, double-stranded DNA substrate mimicking the product of the incision step, we showed that Pol beta is able to catalyze strand displacement downstream of the gap. We discuss these data within the scope of a hypothesis previously presented proposing that excess error-prone Pol beta in cancer cells could perturb the well-defined specific functions of DNA polymerases during error-free DNA transactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973926     DOI: 10.1096/fj.99-1063com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

Review 1.  A novel function of adenomatous polyposis coli (APC) in regulating DNA repair.

Authors:  Aruna S Jaiswal; Satya Narayan
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

2.  Characterization of DNA polymerase beta splicing variants in gastric cancer: the most frequent exon 2-deleted isoform is a non-coding RNA.

Authors:  Valeria Simonelli; Mariarosaria D'Errico; Domenico Palli; Rajendra Prasad; Samuel H Wilson; Eugenia Dogliotti
Journal:  Mutat Res       Date:  2009-07-25       Impact factor: 2.433

3.  Mutagenic Replication of the Major Oxidative Adenine Lesion 7,8-Dihydro-8-oxoadenine by Human DNA Polymerases.

Authors:  Myong-Chul Koag; Hunmin Jung; Seongmin Lee
Journal:  J Am Chem Soc       Date:  2019-03-07       Impact factor: 15.419

4.  Involvement of DNA polymerase β overexpression in the malignant transformation induced by benzo[a]pyrene.

Authors:  Wei Zhao; Mei Wu; Yanhao Lai; Wenwen Deng; Yuan Liu; Zunzhen Zhang
Journal:  Toxicology       Date:  2013-05-04       Impact factor: 4.221

Review 5.  Translesion DNA Synthesis in Cancer: Molecular Mechanisms and Therapeutic Opportunities.

Authors:  Maroof K Zafar; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2017-09-28       Impact factor: 3.739

6.  Structural basis for the inefficient nucleotide incorporation opposite cisplatin-DNA lesion by human DNA polymerase β.

Authors:  Myong-Chul Koag; Lara Lai; Seongmin Lee
Journal:  J Biol Chem       Date:  2014-09-18       Impact factor: 5.157

7.  The evolution of transcription-associated biases of mutations across vertebrates.

Authors:  Paz Polak; Robert Querfurth; Peter F Arndt
Journal:  BMC Evol Biol       Date:  2010-06-18       Impact factor: 3.260

8.  BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability.

Authors:  A Slupianek; R Falinski; P Znojek; T Stoklosa; S Flis; V Doneddu; D Pytel; E Synowiec; J Blasiak; A Bellacosa; T Skorski
Journal:  Leukemia       Date:  2012-10-09       Impact factor: 11.528

9.  DNA polymerase beta overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells.

Authors:  Yvan Canitrot; Jean-Pascal Capp; Nadine Puget; Anne Bieth; Bernard Lopez; Jean-Sébastien Hoffmann; Christophe Cazaux
Journal:  Nucleic Acids Res       Date:  2004-09-27       Impact factor: 16.971

10.  G648C variant of DNA polymerase β sensitizes esophageal cancer to chemotherapy.

Authors:  Yuanyuan Wang; Qianqian Sun; Wei Guo; Xiaonan Chen; Yuwen Du; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.